Literature DB >> 24954007

Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression.

Mar Gacias1, Guillermo Gerona-Navarro2,3, Alexander N Plotnikov2, Guangtao Zhang2, Lei Zeng2, Jasbir Kaur1, Gregory Moy1, Elena Rusinova2, Yoel Rodriguez2,4, Bridget Matikainen1, Adam Vincek2, Jennifer Joshua2, Patrizia Casaccia1, Ming-Ming Zhou2.   

Abstract

Lysine acetylation regulates gene expression through modulating protein-protein interactions in chromatin. Chemical inhibition of acetyl-lysine binding bromodomains of the major chromatin regulators BET (bromodomain and extraterminal domain) proteins has been shown to effectively block cell proliferation in cancer and inflammation. However, whether selective inhibition of individual BET bromodomains has distinctive functional consequences remains only partially understood. In this study, we show that selective chemical inhibition of the first bromodomain of BET proteins using our small-molecule inhibitor, Olinone, accelerated the progression of mouse primary oligodendrocyte progenitors toward differentiation, whereas inhibition of both bromodomains of BET proteins hindered differentiation. This effect was target specific, as it was not detected in cells treated with inactive analogs and independent of any effect on proliferation. Therefore, selective chemical modulation of individual bromodomains, rather than use of broad-based inhibitors, may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24954007      PMCID: PMC4104156          DOI: 10.1016/j.chembiol.2014.05.009

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  40 in total

1.  Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.

Authors:  Bo Huang; Xiao-Dong Yang; Ming-Ming Zhou; Keiko Ozato; Lin-Feng Chen
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

2.  RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.

Authors:  Sarah Picaud; Christopher Wells; Ildiko Felletar; Deborah Brotherton; Sarah Martin; Pavel Savitsky; Beatriz Diez-Dacal; Martin Philpott; Chas Bountra; Hannah Lingard; Oleg Fedorov; Susanne Müller; Paul E Brennan; Stefan Knapp; Panagis Filippakopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

3.  E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation.

Authors:  Laura Magri; Victoria A Swiss; Beata Jablonska; Liang Lei; Xiomara Pedre; Martin Walsh; Weijia Zhang; Vittorio Gallo; Peter Canoll; Patrizia Casaccia
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

4.  Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.

Authors:  Sebastian Schröder; Sungyoo Cho; Lei Zeng; Qiang Zhang; Katrin Kaehlcke; Lily Mak; Joann Lau; Dwayne Bisgrove; Martina Schnölzer; Eric Verdin; Ming-Ming Zhou; Melanie Ott
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

5.  Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4.

Authors:  Cheng-Ming Chiang
Journal:  F1000 Biol Rep       Date:  2009-12-15

Review 6.  The role of human bromodomains in chromatin biology and gene transcription.

Authors:  Roberto Sanchez; Ming-Ming Zhou
Journal:  Curr Opin Drug Discov Devel       Date:  2009-09

7.  A dual-fluorescence high-throughput cell line system for probing multidrug resistance.

Authors:  Kyle R Brimacombe; Matthew D Hall; Douglas S Auld; James Inglese; Christopher P Austin; Michael M Gottesman; King-Leung Fung
Journal:  Assay Drug Dev Technol       Date:  2009-06       Impact factor: 1.738

8.  Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency.

Authors:  Siming Shen; Juan Sandoval; Victoria A Swiss; Jiadong Li; Jeff Dupree; Robin J M Franklin; Patrizia Casaccia-Bonnefil
Journal:  Nat Neurosci       Date:  2008-09       Impact factor: 24.884

9.  Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain.

Authors:  Siming Shen; Jiadong Li; Patrizia Casaccia-Bonnefil
Journal:  J Cell Biol       Date:  2005-05-16       Impact factor: 10.539

10.  Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.

Authors:  Pietro Ciceri; Susanne Müller; Alison O'Mahony; Oleg Fedorov; Panagis Filippakopoulos; Jeremy P Hunt; Elisabeth A Lasater; Gabriel Pallares; Sarah Picaud; Christopher Wells; Sarah Martin; Lisa M Wodicka; Neil P Shah; Daniel K Treiber; Stefan Knapp
Journal:  Nat Chem Biol       Date:  2014-03-02       Impact factor: 15.040

View more
  47 in total

Review 1.  BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.

Authors:  Patricia Cristine Borck; Lian-Wang Guo; Jorge Plutzky
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease.

Authors:  Flor M Mendez; Felipe J Núñez; Maria B Garcia-Fabiani; Santiago Haase; Stephen Carney; Jessica C Gauss; Oren J Becher; Pedro R Lowenstein; Maria G Castro
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

Review 3.  Epigenetics in NG2 glia cells.

Authors:  Sarah Moyon; Jialiang Liang; Patrizia Casaccia
Journal:  Brain Res       Date:  2015-06-17       Impact factor: 3.252

4.  Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis.

Authors:  Forest H Andrews; Alok R Singh; Shweta Joshi; Cassandra A Smith; Guillermo A Morales; Joseph R Garlich; Donald L Durden; Tatiana G Kutateladze
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 5.  Epigenetic drug discovery: breaking through the immune barrier.

Authors:  David F Tough; Paul P Tak; Alexander Tarakhovsky; Rab K Prinjha
Journal:  Nat Rev Drug Discov       Date:  2016-10-21       Impact factor: 84.694

Review 6.  Interplay between transcriptional control and chromatin regulation in the oligodendrocyte lineage.

Authors:  Marylens Hernandez; Patrizia Casaccia
Journal:  Glia       Date:  2015-05-12       Impact factor: 7.452

Review 7.  Bromodomains: Translating the words of lysine acetylation into myelin injury and repair.

Authors:  Achilles Ntranos; Patrizia Casaccia
Journal:  Neurosci Lett       Date:  2015-10-22       Impact factor: 3.046

Review 8.  Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease.

Authors:  Alexander Gregath; Qing Richard Lu
Journal:  FEBS Lett       Date:  2018-02-22       Impact factor: 4.124

Review 9.  Targeting Cancer Cells with BET Bromodomain Inhibitors.

Authors:  Yali Xu; Christopher R Vakoc
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

10.  The Bromodomain: A New Target in Emerging Epigenetic Medicine.

Authors:  Steven G Smith; Ming-Ming Zhou
Journal:  ACS Chem Biol       Date:  2015-12-03       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.